Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
S

ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophylaxis - a QoL Evaluation"

By Insights from 2023 ASH Annual Meeting FEATURING Shernan Holtan
By Insights from 2023 ASH Annual Meeting FEATURING Shernan Holtan
22 views
December 22, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Videos
10:54

Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Dos…

Insights from 2023 ASH Annual Meeting

D. Wolff

94 views
14:54

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has…

Insights from 2023 ASH Annual Meeting

J. Schetelig

52 views
08:49

ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophylaxis…

Insights from 2023 ASH Annual Meeting

S. Holtan

22 views